Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
This study is currently recruiting participants.
Verified May 2010 by Chinese Academy of Medical Sciences
Sponsor:
Chinese Academy of Medical Sciences
Collaborator:
Hoffmann-La Roche
Information provided by:
Chinese Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01126138
First received: May 18, 2010
Last updated: May 3, 2011
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2015 |
| Estimated Primary Completion Date: | May 2015 (Final data collection date for primary outcome measure) |